Tag: Pacific Biosciences of California

  • Small Cap Most Volatile: ReneSola (NYSE:SOL), Pacific Biosciences of California (NASDAQ:PACB), Synergy Pharmaceuticals (NASDAQ:SGYP), Ultrapetrol (NASDAQ:ULTR)

    ReneSola Ltd, (ADR) (NYSE:SOL) a leading brand and technology provider of solar photovoltaic products in Zhejiang province, said that it has been selected as one of the respondents in the US Department of Commerce’s anti-dumping investigation on certain crystalline silicon photovoltaic products from China. ReneSola Ltd. (ADR) (NYSE:SOL) shares after opening at $3.36 moved to $3.39 on last trade day and at the end of the day closed at $3.21. Company price to sales ratio in past twelve months was calculated as 0.24 and price to cash ratio as 3.43. ReneSola Ltd. (ADR) (NYSE:SOL) showed a negative weekly performance of -16.84%.

    Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II, today announced the release of a software upgrade for its Single Molecule, Real-Time (SMRT®) DNA Sequencing platform. SMRT Analysis 2.2 provides enhanced functionality to support two additional applications that uniquely benefit from the company’s long-read sequencing technology: Iso-Seq™ full-length transcript/isoform sequencing, and human leukocyte antigen (HLA) haplotype phasing. Pacific Biosciences of California (NASDAQ:PACB) shares advanced 10.54% in last trading session and ended the day on $5.35. PACB return on equity ratio is recorded as -134.30% and its return on assets is -85.90%. Pacific Biosciences of California (NASDAQ:PACB) yearly performance is 128.63%.

    Investment analysts at Aegis increased their price target on shares ofSynergy Pharmaceuticals (NASDAQ:SGYP) to $28.00 in a note issued to investors on Monday, ARN reports. Aegis’ price target indicates a potential upside of 388.66% from the company’s current price. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares moved up 11.09% in last trading session and was closed at $5.31 while trading in range of $4.75 – $5.36 – Synergy Pharmaceuticals Inc (NASDAQ:SGYP) year to date (YTD) performance is -4.32%.

    Ultrapetrol (Bahamas) Ltd (NASDAQ:ULTR) saw a big move last session, as the company’s shares fell nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ULTR, as the stock is now down about 6% in the past one-month time frame. Ultrapetrol (Bahamas) Limited (NASDAQ:ULTR) weekly performance is -10.40%. On last trading day company shares ended up $3.10. Ultrapetrol (Bahamas) Limited (NASDAQ:ULTR) distance from 50-day simple moving average (SMA50) is -8.25%. Analysts mean target price for the company is $4.75.